@article{156ce04e33b44267884cd41c501a5f84,
title = "Early intervention and prevention of allergic diseases",
abstract = "Food allergy (FA) is now one of the most common chronic diseases of childhood often lasting throughout life and leading to significant worldwide healthcare burden. The precise mechanisms responsible for the development of this inflammatory condition are largely unknown; however, a multifactorial aetiology involving both environmental and genetic contributions is well accepted. A precise understanding of the pathogenesis of FA is an essential first step to developing comprehensive prevention strategies that could mitigate this epidemic. As it is frequently preceded by atopic dermatitis and can be prevented by early antigen introduction, the development of FA is likely facilitated by the improper initial presentation of antigen to the developing immune system. Primary oral exposure of antigens allowing for presentation via a well-developed mucosal immune system, rather than through a disrupted skin epidermal barrier, is essential to prevent FA. In this review, we present the data supporting the necessity of (1) an intact epidermal barrier to prevent epicutaneous antigen presentation, (2) the presence of specific commensal bacteria to maintain an intact mucosal immune system and (3) maternal/infant diet diversity, including vitamins and minerals, and appropriately timed allergenic food introduction to prevent FA.",
keywords = "atopic dermatitis, barrier, food allergy, immune tolerance, prevention",
author = "Brough, {Helen A.} and Lanser, {Bruce Joshua} and Sindher, {Sayantani B.} and Teng, {Joyce M.C.} and Leung, {Donald Y.M.} and Carina Venter and Chan, {Susan M.} and Santos, {Alexandra F.} and Bahnson, {Henry T.} and Emma Guttman-Yassky and Gupta, {Ruchi S.} and Gideon Lack and Ciaccio, {Christina E.} and Vanitha Sampath and Nadeau, {Kari C.} and Nagler, {Cathryn R.}",
note = "Funding Information: We would like to acknowledge Ande Hesser for help with creating Figure 6 for this review and Christopher Warren for creating Figures 1–3 . We would like to thank Anna Globinska, graphics editor at Allergy for support with creating the figures for this review. We thank the Levin Foundation, the Reinhard Foundation, the Sean N. Parker Center for Allergies and Asthma Research at Stanford University, and the NIH (grants R01AI140134 and U19AI070535) for their generous support. Funding Information: Dr. Brough reports receiving research grants from the National Institutes of Health (NIH) (U01 # AI147462), Aimmune and DBV Technologies and speaker fees from DBV Technologies and Sanofi outside of the submitted work. Dr. Lanser reports grants and personal fees from Aimmune Therapeutics, grants and personal fees from DBV Technologies, grants and personal fees from Genentech, personal fees from Allergenis, personal fees from Hycor, personal fees from GSK, grants from US NIH/NIAID‐sponsored Consortium on Food Allergy Research, grants from Regeneron, outside the submitted work. Dr. Sayantani Sindher reports grants from NIH, grants from Regeneron, grants and other from DBV Technologies, grants from AIMMUNE, grants from Novartis, grants from CoFAR, grants and personal fees from FARE, other from Astra Zeneca, outside the submitted work. Dr Chan report grant funding from National Institutes of Health (NIH) (U01 # AI147462) and Aimmune for the ARC005 study. Dr. Santos reports grants and personal fees from Medical Research Council (G0902018, MR/M008517/1 and MR/T032081/1); grants from Food Allergy Research and Education (FARE), Asthma UK and the NIHR through the Biomedical Research Centre (BRC) award to Guy's and St Thomas{\textquoteright} NHS Foundation Trust, during the conduct of the study; grants from Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID, NIH); personal fees from Thermo Scientific, Nutricia, Infomed, Novartis, Allergy Therapeutics, Buhlmann, as well as research support from Buhlmann and Thermo Fisher Scientific through a collaboration agreement with King's College London. Henry Bahnson reports personal fees from King's College, London, UK, during the conduct of the study; personal fees from DBV technologies, outside the submitted work. Guttman‐Yassky reports research funds (grants paid to the institution) from: Abbvie, Almirall, Amgen, AnaptysBio, Asana Biosciences, AstraZeneca, Boerhinger‐Ingelhiem, Cara Therapeutics, Eli Lilly, Galderma, Glenmark/Ichnos Sciences, Innovaderm, Janssen, KAO, Kiniksa, Kyowa Kirin, Leo Pharma, Novan, Pfizer, Ralexar, Regeneron Pharmaceuticals, UCB Consultancy fee from: Abbvie, Almirall, Amgen, Arena, Asana Biosciences, AstraZeneca, Boerhinger‐Ingelhiem, Bristol‐Meyers Squibb, Cara Therapeutics, Connect Pharma, Eli Lilly, EMD Serono, Evidera, Galderma, Ichnos Sciences, Incyte, Janssen Biotech, Kyowa Kirin, Leo Pharma, Pandion Therapeutics, Pfizer, RAPT Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi, SATO Pharmaceutical, Siolta Therapeutics, Target PharmaSolutions, UCB, Ventyx Biosciences. Dr. Gupta reports receiving research support from the National Institutes of Health (NIH) (R21 ID # AI135705, R01 ID # AI130348, U01 ID # AI138907), Food Allergy Research Education (FARE), Rho Inc, Melchiorre Family Foundation, Sunshine Charitable Foundation, Walder Foundation, UnitedHealth Group, Thermo Fisher Scientific, Genentech, and the National Confectioners Association (NCA); serves as a medical consultant/advisor for Aimmune Therapeutics, Before Brands, AllerGenis LLC, Kal{\'e}o Inc, Novartis, Genentech, DBV Technologies, and Food Allergy Research and Education (FARE); is employed by Ann & Robert H. Lurie Children's Hospital of Chicago; and is professor of paediatrics and medicine at Northwestern University Feinberg School of Medicine. Dr. Lack reports grants from National Institute of Allergy and Infectious Diseases (NIAID, NIH), other from Food Allergy & Research Education (FARE), other from MRC & Asthma UK Centre, other from UK Dept of Health through NIHR, other from National Peanut Board (NPB), grants from UK Food Standards Agency (FSA), other from The Davis Foundation,during the conduct of the study; personal fees and other from DBV Technologies, other from Mighty Mission Me, personal fees from Novartis, personal fees from Sanofi‐Genyzme, personal fees from Regeneron, personal fees from ALK‐Abello, personal fees and other from Lurie Children's Hospital,outside the submitted work. Dr. Ciaccio reports personal fees from Novartis, personal fees from ALK, other from Clostrabio, other from Siolta, personal fees from Aimmune, personal fees from DBV, personal fees from Astra‐Zeneca, personal fees from Sanofi Genzyme, outside the submitted work. Dr. Nadeau reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS), and Food Allergy Research & Education (FARE); Director of World Allergy Organization (WAO), Advisor at Cour Pharma, co‐founder of Before Brands, Alladapt, Latitude, and IgGenix; and National Scientific Committee member at Immune Tolerance Network (ITN), and National Institutes of Health (NIH) clinical research centres, outside the submitted work; In addition, Dr. Nadeau has the following patents: Special Oral Formula for Decreasing Food Allergy Risk and Treatment for Food Allergy, Granulocyte‐based methods for detecting and monitoring immune system disorders, Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders, and Microfluidic Device and Diagnostic Methods for Allergy Testing Based on Detection of Basophil Activation. Dr. Nagler reports grants from National Institutes of Health (NIAID) and is the President and co‐founder of ClostraBio, Inc. Dr. Teng and Dr. Sampath report no conflicts of interest. Publisher Copyright: {\textcopyright} 2021 EAACI and John Wiley and Sons A/S Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
doi = "10.1111/all.15006",
language = "English",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "John Wiley and sons",
}